Loading…

Loading grant details…

Completed HORIZON European Commission

A prosthetic heart valve for adults and children, made from the patient’s own tissue, a replacement heart valve that lasts a lifetime

€3.61M EUR

Funder European Commission
Recipient Organization Grownvalve Gmbh
Country Germany
Start Date Apr 01, 2022
End Date Mar 31, 2025
Duration 1,095 days
Number of Grantees 1
Roles Coordinator
Data Source European Commission
Grant ID 190188598
Grant Description

Each year 400,000 people are born with heart valve defects worldwide. Moreover, in the western world, 1 in 8 healthy adults will develop a heart valve problem during their lifetime.

Current artificial heart valves made from animal or human donor tissue carry a high risk of tissue rejection, degradation and calcification that limit their lifespan to about 10-years, forcing patients to undergo risky cardiac re-surgery.

For children, no dedicated valve product exists, thus, paediatric patients can endure 4-5 surgeries between 0-18-years of age as their bodies outgrow each replacement heart valve.

At GrOwnValve we have developed a paradigm shift in heart valve technology: the first autologous valve, grown from the patient’s own tissue, crafted using medical imaging and a 3D printing technique.

Our valve lasts a lifetime, eliminating tissue rejection and surgical risks associated with repeated surgery (bleeding, infection and death).

All Grantees

Grownvalve Gmbh

Advertisement
Apply for grants with GrantFunds
Advertisement
Browse Grants on GrantFunds
Interested in applying for this grant?

Complete our application form to express your interest and we'll guide you through the process.

Apply for This Grant